Download presentation
Presentation is loading. Please wait.
Published byGarey Phelps Modified over 6 years ago
1
Biological agents that might be used as weapons of Bioterrorism
Example of Anthrax: Bacillus anthracis Ramatoulaye BARRY M2 AREIPS November 15th 2016
2
TABLE OF CONTENTS I- Bioterrorism II- Regulation
1- Overview 2- Categorisation II- Regulation 1- In Europe : Guidance document on use of medicinal products for the treatment and prophylaxis of biological agents that might be used as weapons of bioterrorism 2- In USA : The Bioterrorism Act III- Example of Anthrax 2- Context 3- Recommendations Ramatoulaye BARRY
3
I- BIOTERRORISM Ramatoulaye BARRY
4
in people, animals, or plants
1- Overview A bioterrorism attack is the deliberate release of viruses, bacteria, or other germs used to cause illness or death in people, animals, or plants Biological agents : found in nature spread through the air, through water, or in food could be changed extremely difficult to detect Ramatoulaye BARRY
5
2- Categorisation Three categories, depending on: Two classifications:
How easily they can be spread The severity of illness they cause Two classifications: The EMA Categorisation The CDC Categorisation Ramatoulaye BARRY
6
2- Categorisation The Centers for Disease Control and Prevention CDC = the leading national public health institute of the United States ☛ To protect public health and safety through the control and prevention of disease Ramatoulaye BARRY
7
2- Categorisation CDC Categorisation Category A: The highest priority
easily spread or transmitted high death rates public panic special action for public health preparedness Examples: Anthrax and Smallpox virus Ramatoulaye BARRY
8
2- Categorisation CDC Categories Category B: The 2nd highest priority
moderately easy to spread moderate illness rates and low death rates specific enhancements of CDC's laboratory capacity and enhanced disease monitoring Example: Brucellosis Ramatoulaye BARRY
9
2- Categorisation CDC Categories Category C: The 3rd highest priority
Emerging pathogens easily available easily produced and spread high morbidity and mortality rates and major health impact Example: H1N1 Ramatoulaye BARRY
10
II- REGULATION Ramatoulaye BARRY
11
1- In Europe Guidance document on use of medicinal products
for the treatment and prophylaxis of biological agents that might be used as weapons of bioterrorism = a guidance document on the use of medicinal products for treatment and prophylaxis of biological agents that might be used as weapons of bioterrorism Ramatoulaye BARRY
12
2- In the US The Public Health Security and Bioterrorism Preparedness and Response Act of 2002: the Bioterrorism Act The events of Sept. 11, 2001: need to enhance the security of the United States Signed by President BUSH into law June 12, 2002 Divided into 5 titles : Title I: National Preparedness for Bioterrorism and Other Public Health Emergencies Title II: Enhancing Controls on Dangerous Biological Agents and Toxins Title III: Protecting Safety and Security of Food and Drug Supply Title IV: Drinking Water Security and Safety Title V: Additional Provisions Ramatoulaye BARRY
13
III- Example of Anthrax
Ramatoulaye BARRY
14
1- Overview A serious infectious disease Gram-positive, rod-shaped bacteria : Bacillus anthracis Ramatoulaye BARRY
15
1- Overview Different types of Anthrax: All type of Anthrax can cause death Ramatoulaye BARRY
16
Focus on Inhalation Anthrax
1- Overview Focus on Inhalation Anthrax Symptoms Fever Chills Drenching sweats Profound fatigue Minimally productive cough Nausea or vomiting Chest discomfort Ramatoulaye BARRY
17
The 2001 Anthrax attacks/ Amerithrax
2- Context The 2001 Anthrax attacks/ Amerithrax Concentrated anthrax spores were used for bioterrorism in the United States Delivered by mailing postal letters containing the spores One week after the September 11 attacks Ramatoulaye BARRY
18
3- Recommendations EU Guidance on the use of medicines
for the treatment and prevention of biological agents Ciprofloxacine : First line treatment
First line prophylaxis Ramatoulaye BARRY
19
3- Recommendations Treatment Prophylaxis
Ciprofloxaxine : 400 mg iv twice daily followed by 500 mg orally twice daily Duration : 60 days Prophylaxis Ciprofloxacine: 500 mg orally twice daily Ramatoulaye BARRY
20
To conclude Bioterrorism: A concerning threat In Europe: Difficulty to harmonise advices Ramatoulaye BARRY
21
Thank you ! Ramatoulaye BARRY
22
Bibliography mid=WC0b01ac a5 WC pdf Ramatoulaye BARRY
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.